Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
- Status
- UNKNOWN
- Phase
- PHASE2
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- NA
The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- NA
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.
- Status
- RECRUITING
- Phase
- N/A
Sleep in Adults With Down Syndrome and Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- N/A
CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Effect of REST in the Alzheimer Disease Continuum
- Status
- COMPLETED
- Phase
- N/A
Trial of Rifaximin in Probable Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
In-Home Technology for Dementia Caregivers
- Status
- COMPLETED
- Phase
- NA
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- UNKNOWN
- Phase
- PHASE2
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
- Status
- WITHDRAWN
- Phase
- PHASE1
An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE2
Prazosin for Agitation in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE1